Detection of co-occuring mental illness among adult patients in the New Jersey substance abuse treatment system

American Journal of Public Health

Volumn 96, Issue 10, 2006, Pages 1785-1793

  Hu, Hsou Mei ^b   Kline, Anna ^a   Huang, Frederick Y ^c   Ziedonis, Douglas M ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; AFRICAN AMERICAN; ARTICLE; COMORBIDITY; CRIMINAL JUSTICE; DRUG DEPENDENCE TREATMENT; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; METHADONE TREATMENT; PATIENT REFERRAL; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT OUTCOME; UNITED STATES; ADDICTION; AMERICAN INDIAN; MEDICAL RECORD; MIDDLE AGED;

ADULT; COMORBIDITY; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; MEDICAL RECORDS; MENTAL DISORDERS; MIDDLE AGED; NEW JERSEY; SUBSTANCE-RELATED DISORDERS;

EID: 33749328797     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2005.072736     Document Type: Article

References (43)

1. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66:17-31.
2. Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. Rockvffle, Md: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2002. DHHS Publication SMA 02-3758.
3. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61:807-816.
4. King RD, Gaines LS, Lambert EW, Summerfelt WT, Bickman L. The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. J Behav Health Serv Res. 2000;27:417-430.
5. Steadman HJ, Mulvey EP, Monahan J, et al. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Arch Gen Psychiatry. 1998;55:393-401.
6. Abram KM, Teplin LA. Co-occurring disorders among mentally ill jail detainees. Implications for public policy. Am Psychol. 1991;46:1036-1045.
7. Abram KM, Teplin LA, McClelland GM. Comorbidity of severe psychiatric disorders and substance use disorders among women in jail. Am J Psychiatry. 2003; 160:1007-1010.
8. Abram KM, Teplin LA, McClelland GM, Dulcan MK. Comorbid psychiatric disorders in youth in juvenile detention. Arch Gen Psychiatry. 2003;60:1097-1108.
9. Coodin S, Staley D, Cortens B, Desrochers R, McLandress S. Patient factors associated with missed appointments in persons with schizophrenia. Can J Psychiatry. 2004;49:145-148.
10. Hudson TJ, Owen RR, Thrush CR, et al. A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry. 2004;65:211-216.
11. Rosenberg SD. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001;91:31-37.
12. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry. 1998;155:226-231.
13. The role of co-occurring substance abuse and mental illness in violence: workshop summary. Washington, DC: Institute of Medicine, Division of Neuroscience and Behavioral Health; 1999.
14. Kline A, Mammo A., Culleton R., Crowley C, Barton C. National Evaluation Data: Treatment Access and Service Utilization by Clients in the Substance Abuse and Mental Health Treatment Systems System. Trenton, NJ: New Jersey Department of Health and Senior Services, Division of Addiction Services; 2002.
15. Drake RE, McLaughlin P, Pepper B, Minkoff K. Dual diagnosis of major mental illness and substance disorder: an overview. New Dir Ment Health Serv. 1991;50:3-12.
16. Ananth J, Vandewater S, Kamal M, Brodsky A, Gamal R, Miller M. Missed diagnosis of substance abuse in psychiatric patients. Hosp Community Psychiatry. 1989;40:297-299.
17. King RD, Gaines LS, Lambert EW, Summerfelt WT, Bickman L. The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. J Behav Health Serv Res. 2000;27:417-430.
18. Report to Congress on the Prevention and Treatment of Co-Occurring Substance Abuse Disorders and Mental Disorders. Rockville, Md: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Available at: http://alt.samhsa.gov/reports/congress2002/index. html. Accessed December 2004.
19. Durell J, Lechtenberg B, Corse S, Frances RJ. Intensive case management of persons with chronic mental illness who abuse substances. Hosp Community Psychiatry. 1993;44:415-416, 428.
20. Drake RE, Yovetich NA, Bebout RR, Harris M, McHugo GJ. Integrated treatment for dually diagnosed homeless adults. J Nerv Ment Dis. 1997;185:298-305.
21. Drake RE, Essock SM, Shaner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv. 2001;52:469-476.
22. Borowsky SJ, Rubenstein LV, Meredith LS, Camp P, Jackson-Trihe M, Wells KB. Who is at risk of nondetection of mental health problems in primary care? J Gen Intern Med. 2000;15:381-388.
23. Smith MV, Rosenheck RA, Cavaleri MA, Howell HB, Poschman K, Yonkers KA. Screening for and detection of depression, panic disorder, and PTSD in public-sector obstetric clinics. Psychiatr Serv. 2004; 55:407-414.
24. Fink P, Orbol E, Hansen MS, Sondergaard L, De Jonge P. Detecting mental disorders in general hospitals by the SCL-8 scale. J Psychosom Res. 2004;56:371-375.
25. Zatzick D, Russo J, Rivara F, Roy-Byrne P, Jurkovich G, Katon W. The detection and treatment of posttraumatic distress and substance intoxication in the acute care inpatient setting. Gen Hosp Psychiatry. 2005; 27:57-62.
26. Kline A, Barton C, Bruzios C, Merrill J, Kyllingstad A, Violette N. The New Jersey Treatment Outcome and Performance Pilot Study II: Final Project Report. Trenton, NJ: New Jersey Department of Health and Senior Services; 2003.
27. Green-Hennessy S. Factors associated with receipt of behavioral health services among persons with substance dependence. Psychiatr Serv. 2002;53:1592-1598.
28. Watkins KE, Burnam A, Kung F, Paddock S. A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatr Serv. 2001;52:1062-1068.
29. Wells K, Klap R, Koike A, Sherbourne C. Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. Am J Psychiatry. 2001;158: 2027-2032.
30. Wang PS, Demler O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am J Public Health. 2002;92:92-98.
31. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:629-640.
32. Johnson ME, Brems C, Burke S. Recognizing comorbidity among drug users in treatment. Am J Drug Alcohol Abuse. 2002;28:243-261.
33. Ziedonis DM. Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectr. 2004;9: 892-904, 925.
34. Neighbors HW, Jackson JS, Campbell L, Williams D. The influence of racial factors on psychiatric diagnosis: a review and suggestions for research. Community Ment Health J. 1989;25:301-311.
35. Baker FM, Bell CC. Issues in the psychiatric treatment of African Americans. Psychiatr Serv. 1999; 50:362-368.
36. King VL, Kidorf MS, Stoller KB, Carter JA, Brooner RK. Influence of antisocial personality subtypes on drug abuse treatment response. J Nerv Ment Dis. 2001;189:593-601.
37. Chen CC, Tsai SY, Su LW, Yang TW, Tsai CJ, Hwu HG. Psychiatric co-morbidity among male heroin addicts: differences between hospital and incarcerated subjects in Taiwan. Addiction. 1999;94:825-832.
38. Ditton PM. Mental Health and Treatment of Inmates and Probationers. Washington, DC: US Department of Justice; 1999.
39. Swartz JA, Lurigio AJ. Psychiatric illness and comorbidity among adult male jail detainees in drug treatment Psychiatr Serv. 1999;50:1628-1630.
40. Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer? Compr Psychiatry. 1995;36:278-288.
41. McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved diagnostic instrument for substance abuse patients: The Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33.
42. Beck AT, Steer RA, Brown GK. BDI-II, Beck Depression Inventory: Manual. 2nd ed. San Antonio, Tex: Psychological Corp.; 1996.
43. Substance Abuse Treatment for Persons with Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. Rockville, Md: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 2005. DHHS Publication SMA 05-3992.